Harish Seethapathy

1.6k total citations
40 papers, 751 citations indexed

About

Harish Seethapathy is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Oncology. According to data from OpenAlex, Harish Seethapathy has authored 40 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 13 papers in Nephrology and 13 papers in Oncology. Recurrent topics in Harish Seethapathy's work include Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal cell carcinoma treatment (5 papers). Harish Seethapathy is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Renal Diseases and Glomerulopathies (8 papers) and Renal cell carcinoma treatment (5 papers). Harish Seethapathy collaborates with scholars based in United States, Germany and United Kingdom. Harish Seethapathy's co-authors include Meghan E. Sise, Kerry L. Reynolds, Ian A. Strohbehn, David E. Leaf, Sophia Zhao, Donald F. Chute, Ryan J. Sullivan, Leyre Zubiri, Alexandra–Chloé Villani and Frank B. Cortazar and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of the American Society of Nephrology.

In The Last Decade

Harish Seethapathy

33 papers receiving 737 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harish Seethapathy United States 15 416 252 172 106 77 40 751
Ian A. Strohbehn United States 12 325 0.8× 173 0.7× 135 0.8× 67 0.6× 55 0.7× 28 592
Amit Lahoti United States 13 279 0.7× 382 1.5× 306 1.8× 147 1.4× 47 0.6× 21 943
E. Cassuto‐Viguier France 13 232 0.6× 155 0.6× 127 0.7× 210 2.0× 98 1.3× 35 1.0k
Aleksandra Kukla United States 20 176 0.4× 273 1.1× 300 1.7× 401 3.8× 62 0.8× 64 1.2k
Elie Mouhayar United States 15 188 0.5× 144 0.6× 49 0.3× 92 0.9× 16 0.2× 45 669
Yoshiya Yamamoto Japan 19 161 0.4× 198 0.8× 151 0.9× 162 1.5× 28 0.4× 71 1.1k
Olga Meltem Akay Türkiye 15 106 0.3× 103 0.4× 48 0.3× 69 0.7× 91 1.2× 83 678
Rajeev Parameswaran Singapore 19 142 0.3× 351 1.4× 130 0.8× 692 6.5× 28 0.4× 79 1.1k
Sophie Séronie-Vivien France 11 157 0.4× 132 0.5× 288 1.7× 47 0.4× 16 0.2× 23 744
Neil McGill Australia 15 102 0.2× 152 0.6× 222 1.3× 224 2.1× 25 0.3× 35 735

Countries citing papers authored by Harish Seethapathy

Since Specialization
Citations

This map shows the geographic impact of Harish Seethapathy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harish Seethapathy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harish Seethapathy more than expected).

Fields of papers citing papers by Harish Seethapathy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harish Seethapathy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harish Seethapathy. The network helps show where Harish Seethapathy may publish in the future.

Co-authorship network of co-authors of Harish Seethapathy

This figure shows the co-authorship network connecting the top 25 collaborators of Harish Seethapathy. A scholar is included among the top collaborators of Harish Seethapathy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harish Seethapathy. Harish Seethapathy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mehr, Ali Poyan, et al.. (2025). Updates on Glomerular Diseases: A Summary of Inaugural GlomCon Hawaii 2024. PubMed. 5(1). 158–167. 1 indexed citations
2.
3.
Gibson, Keisha L., et al.. (2024). Minimal Change Disease. PubMed. 31(4). 267–274. 2 indexed citations
4.
Zonozi, Reza, Harish Seethapathy, Orhan Efe, et al.. (2024). Combination Induction Immunosuppression With Rituximab, Cyclophosphamide, and Prednisone for Fibrillary Glomerulonephritis. Kidney International Reports. 10(3). 944–947.
5.
Sise, Meghan E., Qiyu Wang, Harish Seethapathy, et al.. (2023). Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritis. Journal for ImmunoTherapy of Cancer. 11(1). e006222–e006222. 23 indexed citations
6.
Wang, Qiyu, Ian A. Strohbehn, Harish Seethapathy, et al.. (2023). Medication-Related Adverse Events and Discordancies in Cystatin C–Based vs Serum Creatinine–Based Estimated Glomerular Filtration Rate in Patients With Cancer. JAMA Network Open. 6(7). e2321715–e2321715. 16 indexed citations
7.
Workeneh, Biruh, et al.. (2022). Sodium and Potassium Dysregulation in the Patient With Cancer. Advances in Chronic Kidney Disease. 29(2). 171–179.e1. 11 indexed citations
8.
Seethapathy, Harish, Sandra M. Herrmann, & Arash Rashidi. (2022). Immune Checkpoint Inhibitor–Associated AKI: Debates in Diagnosis, Management, and Rechallenge. Seminars in Nephrology. 42(6). 151346–151346. 2 indexed citations
9.
Seethapathy, Harish, et al.. (2021). Glomerular Disease Education Experience across Nephrology Fellowship Programs: An International Survey. SHILAP Revista de lepidopterología. 2(2). 89–94. 1 indexed citations
10.
Lee, Meghan, Harish Seethapathy, Orhan Efe, et al.. (2020). Dabrafenib-Induced Acute Interstitial Nephritis (AIN) and AKI in Patients with Cancer. Journal of the American Society of Nephrology. 31(10S). 664–664.
11.
Lee, Meghan, Ian A. Strohbehn, Harish Seethapathy, et al.. (2020). Clinical Features of AKI in Patients Receiving Tisagenlecleucel (CAR-T Therapy). Journal of the American Society of Nephrology. 31(10S). 664–664.
12.
Gupta, Shruti, Harish Seethapathy, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury and Electrolyte Abnormalities After Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Diffuse Large B-Cell Lymphoma. American Journal of Kidney Diseases. 76(1). 63–71. 80 indexed citations
13.
Seethapathy, Harish, Donald F. Chute, Ian A. Strohbehn, et al.. (2020). Acute Kidney Injury Following Encorafenib and Binimetinib for Metastatic Melanoma. Kidney Medicine. 2(3). 373–375. 7 indexed citations
14.
Seethapathy, Harish, Sophia Zhao, Ian A. Strohbehn, et al.. (2020). Incidence and Clinical Features of Immune-Related Acute Kidney Injury in Patients Receiving Programmed Cell Death Ligand-1 Inhibitors. Kidney International Reports. 5(10). 1700–1705. 43 indexed citations
15.
Seethapathy, Harish, Sophia Zhao, Donald F. Chute, et al.. (2019). The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint Inhibitors. Clinical Journal of the American Society of Nephrology. 14(12). 1692–1700. 205 indexed citations
16.
Seethapathy, Harish, et al.. (2019). Validity of International Classification of Diseases Codes for Sickle Cell Trait and Sickle Cell Disease. Journal of General Internal Medicine. 35(4). 1323–1324. 4 indexed citations
17.
Sise, Meghan E., Harish Seethapathy, & Kerry L. Reynolds. (2019). Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. The Oncologist. 24(6). 735–742. 41 indexed citations
18.
Seethapathy, Harish & Andrew Z. Fenves. (2019). Pathophysiology and Management of Hyperammonemia in Organ Transplant Patients. American Journal of Kidney Diseases. 74(3). 390–398. 14 indexed citations
19.
Seethapathy, Harish & Sagar U. Nigwekar. (2019). Revisiting therapeutic options for calciphylaxis. Current Opinion in Nephrology & Hypertension. 28(5). 448–454. 5 indexed citations
20.
Allegretti, Andrew S., Darrick K. Li, Harish Seethapathy, et al.. (2019). Evaluation of model performance to predict survival after transjugular intrahepatic portosystemic shunt placement. PLoS ONE. 14(5). e0217442–e0217442. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ian A. Strohbehn Breakdown of academic impact, for papers by Amit Lahoti Breakdown of academic impact, for papers by E. Cassuto‐Viguier Breakdown of academic impact, for papers by Aleksandra Kukla Breakdown of academic impact, for papers by Elie Mouhayar Breakdown of academic impact, for papers by Yoshiya Yamamoto Breakdown of academic impact, for papers by Olga Meltem Akay Breakdown of academic impact, for papers by Rajeev Parameswaran Breakdown of academic impact, for papers by Sophie Séronie-Vivien Breakdown of academic impact, for papers by Neil McGill
Rankless by CCL
2026